256 related articles for article (PubMed ID: 32476509)
1. Epigenetics factors in nonalcoholic fatty liver disease.
Pirola CJ; Sookoian S
Expert Rev Gastroenterol Hepatol; 2022 Jun; 16(6):521-536. PubMed ID: 32476509
[No Abstract] [Full Text] [Related]
2. Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review.
Zhang X; Asllanaj E; Amiri M; Portilla-Fernandez E; Bramer WM; Nano J; Voortman T; Pan Q; Ghanbari M
Eur J Clin Invest; 2021 May; 51(5):e13479. PubMed ID: 33350463
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition.
Lee JH; Friso S; Choi SW
Nutrients; 2014 Aug; 6(8):3303-25. PubMed ID: 25195642
[TBL] [Abstract][Full Text] [Related]
4. Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis.
Chung KW; Cho YE; Kim SJ; Hwang S
Arch Pharm Res; 2022 Apr; 45(4):229-244. PubMed ID: 35391713
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in non-alcoholic fatty liver disease.
Lee J; Kim Y; Friso S; Choi SW
Mol Aspects Med; 2017 Apr; 54():78-88. PubMed ID: 27889327
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease.
Coronel-Castillo CE; Qi X; Contreras-Carmona J; Ramírez-Pérez OL; Méndez-Sánchez N
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):531-540. PubMed ID: 30905208
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
8. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases.
Campisano S; La Colla A; Echarte SM; Chisari AN
Nutr Res Rev; 2019 Jun; 32(1):128-145. PubMed ID: 30707092
[TBL] [Abstract][Full Text] [Related]
9. Metabolic-associated Fatty Liver Disease Regulation through Nutri Epigenetic Methylation.
Rivera-Aguirre J; López-Sánchez GN; Chávez-Tapia NC; Uribe M; Nuño-Lámbarri N
Mini Rev Med Chem; 2023; 23(17):1680-1690. PubMed ID: 36718062
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease.
Stols-Gonçalves D; Tristão LS; Henneman P; Nieuwdorp M
Curr Diab Rep; 2019 May; 19(6):31. PubMed ID: 31044315
[TBL] [Abstract][Full Text] [Related]
11. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Soejima Y; Fukusato T
World J Gastroenterol; 2012 May; 18(19):2300-8. PubMed ID: 22654421
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation in Nonalcoholic Fatty Liver Disease.
Hyun J; Jung Y
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143364
[TBL] [Abstract][Full Text] [Related]
13. Potential epigenetic mechanism in non-alcoholic Fatty liver disease.
Sun C; Fan JG; Qiao L
Int J Mol Sci; 2015 Mar; 16(3):5161-79. PubMed ID: 25751727
[TBL] [Abstract][Full Text] [Related]
14. Genetics and epigenetics purpose in nonalcoholic fatty liver disease.
Botello-Manilla AE; Chávez-Tapia NC; Uribe M; Nuño-Lámbarri N
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):733-748. PubMed ID: 32552211
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease.
Ashraf NU; Altaf M
Mutat Res Rev Mutat Res; 2018; 778():1-12. PubMed ID: 30454678
[TBL] [Abstract][Full Text] [Related]
16. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
17. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.
Li YY
World J Gastroenterol; 2012 Dec; 18(45):6546-51. PubMed ID: 23236228
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
Fang Z; Dou G; Wang L
Int J Biol Sci; 2021; 17(7):1851-1863. PubMed ID: 33994867
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
Lim S; Taskinen MR; Borén J
Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
